Effect of Sulodexide in Early Diabetic Nephropathy

NCT00130208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1056

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Sulodexide
DRUG: Placebo

Sponsor

Keryx Biopharmaceuticals

Collaborators

[object Object]